The following are new and competing renewal awards made to faculty in the Department of Pediatrics for the month of May 2021.
Michael Cohen-Wolkowiez, MD, PhD (Infectious Diseases) received an award from the National Institutes of Health/NICHD in the amount of $920,200 for an award entitled Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program. The project period is 05/01/2021-04/30/2026.
Neil Surana, MD, PhD (Infectious Diseases) and Teresa McDonald (Graduate Student) received an award from the National Science Foundation in the amount of $138,000 for an award entitled NSF Graduate Research Fellowship Award. The project period is 09/01/2021-08/31/2024.
Dwight Koeberl, MD, PhD (Medical Genetics) received an award from Lysoway Therapeutics in the amount of $47,786 for an award entitled Lysoway GSD 1a Research. The project period is 04/01/2021-03/31/2022.
Sierra Atwater (Medical Student) and Debra Lugo, MD (Infectious Diseases) received an award from the American Society of Hematology in the amount of $36,000 for an award entitled Optimizing Clostridium Difficile Diagnoses in High-Risk Hospitalized Pediatric Patients with Hematologic Malignancies or Undergoing, Hematopoietic Stem Cell Transplantation. The project period is 07/01/2021-06/30/2022.
William Steinbach, MD and Praveen Juvvadi, PhD (Infectious Diseases) received an award from the National Institutes of Health/NIAID in the amount of $$442,750 for an award entitled Calcineurin Regulatory Network Control of Aspergillus Fumigatus Hyphal Septation. The project period is 06/01/2021-05/31/2023.
Jessica Sun, MD (Hematology-Oncology) received an award from Actuate Therapeutics in the amount of $71,085 for an award entitled A Phase 1 study of 9-ING-41, a Glycogen Synthase Kinase-3 Beta (GSK-3b) inhibitor. The project period is 04/28/2021-04/30/2025.
Muhammad Zafar, MBBS (Neurology) received an award from UCB Biopharma in the amount of $112,923 for an award entitled An open-label, long-term safety and tolerability study of bivaracetam as adjunctive treatment in pediatric study participants with epilepsy. The project period is 05/12/2021-01/31/2023.
Congratulations to these faculty on their awards and best wishes to them in their investigative work.
William J. Steinbach, MD
Vice Chair, Research
Samuel L. Katz Distinguished Professor of Pediatrics
Chief, Division of Infectious Diseases
Interim Chief, Divsion of Transplant and Cellular Therapy
Professor in Molecular Genetics and Microbiology